PAFAH1B3 is elevated in human pan-cancer, which is correlated with greater pathology and poor prognosis, in particular for NSCLC and liver hepatocellular carcinoma (LIHC)43. This evidence concerns the gene PAFAH1B3 and non-small cell lung carcinoma.